Teradyne, Inc. · Technology
Paid for today, but breaks on a small cut — or only looks over-priced at a 9% discount rate.
At 25.0% margin the price requires 18.8% 3y revenue CAGR vs consensus 37.5%, a cushion of +7.1pt (+10.8pt at 1pt lower r) against a 19pt correction cut. At 25% margin the price needs 18.8% vs 37.5% consensus. The 7.1pt cushion survives a flush but not the 19pt bust that AI-test digestion implies.
Breaks if: Accelerator test volume is pushed out in 2027 guides, or SoC test share slips.. We re-check this against analyst estimates every evening.
10 years, at a 25% margin analysts expect
+22.9%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
8 published targets, set before the drop
Linked to AMD, AMZN, NVDA, TSM
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 125% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 11, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price sits at the very bottom of the published analyst targets, fully endorsing only the $397 Morgan Stanley view and rejecting the five bull cases up to $550, meaning it assumes the current AI-driven surge will not sustain the 30.7% revenue growth the reverse-DCF requires.
The central question is whether AI-driven test demand can sustain 30%+ revenue growth and hold a 37.5% operating margin, and while the available data can measure the unit volumes to confirm the revenue trajectory, it cannot measure the 1.6T pricing premium that justifies the margin.
What the price refuses to pay for, and the full reconstruction, on the TER quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names